First-in-human, Safety, Tolerability and Pharmacokinetics Study of LRX712 in Osteoarthritic Patients
Clinical trial NCT03355196 · COMPLETED
Trial details
- NCT number
- NCT03355196
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-20
- Primary completion
- 2019-03-26
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.